These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2720741)

  • 21. [Course of ventricular arrhythmias following myocardial infarction. Results of a 2-year follow-up].
    Medvedowsky JL; Barnay C; Arnaud C; Bonet P
    Arch Mal Coeur Vaiss; 1984 Jul; 77(7):754-65. PubMed ID: 6433838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arrhythmias and sudden death after dynamic cardiomyoplasty.
    Bocchi EA; Moreira LF; de Moraes AV; Bacal F; Sosa E; Stolf NA; Bellotti G; Jatene AD; Pilleggi F
    Circulation; 1994 Nov; 90(5 Pt 2):II107-11. PubMed ID: 7955235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Electrocardiographic changes in patients with chronic anemia].
    Stanojević M; Stankov S
    Srp Arh Celok Lek; 1998; 126(11-12):461-6. PubMed ID: 9921020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute arrhythmogenicity of first-dose chemotherapeutic agents in children.
    Massin MM; Dresse MF; Schmitz V; Hoyoux C; Chantraine JM; Lepage P
    Med Pediatr Oncol; 2002 Aug; 39(2):93-8. PubMed ID: 12116056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart rate variability in patients suffering from structural heart disease and decreased AV-nodal conduction capacity. Insights into the formation of heart rate variability.
    Schwab JO; Eichner G; Schmitt H; Schrickel J; Yang A; Balta O; Lüderitz B; Lewalter T
    Z Kardiol; 2004 Mar; 93(3):229-33. PubMed ID: 15024591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal repolarization inhomogeneity and reperfusion arrhythmias in patients undergoing successful primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: impact of admission troponin T.
    Bonnemeier H; Wiegand UK; Giannitsis E; Schulenburg S; Hartmann F; Kurowski V; Bode F; Tölg R; Katus HA; Richardt G
    Am Heart J; 2003 Mar; 145(3):484-92. PubMed ID: 12660672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac arrhythmias in aluminium phosphide poisoning studied by on continuous holter and cardioscopic monitoring.
    Siwach SB; Singh H; Jagdish ; Katyal VK; Bhardwaj G
    J Assoc Physicians India; 1998 Jul; 46(7):598-601. PubMed ID: 12152839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Results of the systematic application of ventricular stimulation methods].
    Perrot B; Thiel B; Cherrier F; Faivre G
    Arch Mal Coeur Vaiss; 1984 Mar; 77(3):262-72. PubMed ID: 6424612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Acute cardiotoxicity of anthracyclines--analysis by using Holter ECG].
    Okuma K; Furuta I; Ota K
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):902-11. PubMed ID: 6202243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac effects of sumatriptan: findings of Holter monitoring and review of the literature.
    Wöber C; Wessely P; Frey B; Marterer A; Zeiler K
    Wien Klin Wochenschr; 1998 May; 110(9):331-7. PubMed ID: 9629625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk stratification for malignant arrhythmic events in patients with an acute myocardial infarction: role of an open infarct-related artery and the signal-averaged ECG.
    Hermosillo AG; Araya V; Casanova JM
    Coron Artery Dis; 1995 Dec; 6(12):973-83. PubMed ID: 8723020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Programmed electric stimulation following acute myocardial infarct. Significance of stimulation timing].
    Costard A; Schlüter M; Kunze KP; Wolf U; Kuck KH
    Z Kardiol; 1986 Oct; 75(10):589-97. PubMed ID: 3788250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of arrhythmic events during second day monitoring in patients with normal first day Holter recordings.
    Arya A; Haghjoo M; Khosrawi A; Emkanjoo Z; Sadr-Ameli MA
    Indian Heart J; 2005; 57(3):241-4. PubMed ID: 16196182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Identification of patients at risk of malignant arrhythmia in the 1st year after myocardial infarction].
    Araya-Gómez V; González-Hermosillo JA; Casanova Garcés JM; Colín L; Kershenovich S; Iturralde P
    Arch Inst Cardiol Mex; 1994; 64(2):145-59. PubMed ID: 8074586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Programmed stimulation in patients with malignant ventricular arrhythmias. I: Diagnostic value].
    Senges J; Lengfelder W; Jauernig R; Brachmann J; Rizos I; Kübler W
    Herz; 1984 Feb; 9(1):45-51. PubMed ID: 6200414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrocardiographic monitoring of patients receiving phase I cancer chemotherapy.
    Hersh MR; Linn W; Kuhn JG; Von Hoff DD
    Cancer Treat Rep; 1986 Mar; 70(3):349-52. PubMed ID: 3955546
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relation between disorders of cardiac rhythm to the symptomatology and extent of hypertrophic cardiomyopathy].
    Gregor P; Widimský P; Kohout P; Sochor K; Bufka V; Cervenka V; Vísek V
    Vnitr Lek; 1989 Jul; 35(7):632-8. PubMed ID: 2800367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dobutamine effects on spontaneous variability of ventricular arrhythmias in patients with severe chronic heart failure: the Italian Multicenter Study.
    Puddu PE; Papalia U; Schiariti M; Usta C;
    Ital Heart J; 2004 Sep; 5(9):693-701. PubMed ID: 15568599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term electrocardiography (quality standards and guidelines for the documentation of findings].
    Kühn P
    Wien Med Wochenschr; 1988 Jan; 138(1-2):2-5. PubMed ID: 2451358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes in the R-ST segment in dynamic monitoring (Holter system)].
    Boasso M; Conte MR; Palmara F; Gaita F; Bonamini R; Rosettani E
    Boll Soc Ital Cardiol; 1977; 22(11):2147-9. PubMed ID: 754763
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.